Perivascular enhancement in anti-MOG antibody demyelinating disease of the CNS

J Neurol Neurosurg Psychiatry. 2019 Jan;90(1):111-112. doi: 10.1136/jnnp-2018-319235. Epub 2018 Oct 8.

Authors

Teppei Komatsu¹, Satoshi Matsushima², Kimihiko Kaneko³, Takahiro Fukuda⁴

Affiliations

¹ Department of Neurology, the Jikei University School of Medicine, Tokyo, Japan teppeinoieni.coicoi@jikei.ac.jp.
² Department of Radiology, the Jikei University School of Medicine, Tokyo, Japan.
³ Department of Neurology, National Hospital Organization Miyagi Hospital, Miyagi, Japan.
⁴ Division of Neuropathology, Department of Pathology, the Jikei University School of Medicine, Tokyo, Japan.

PMID: 30297517
DOI: 10.1136/jnnp-2018-319235

No abstract available

Keywords: perivascular enhancement and anti-MOG antibody.

Publication types

Case Reports

MeSH terms

Autoantibodies / immunology*
Biopsy
Brain / diagnostic imaging*
Brain / pathology
Demyelinating Autoimmune Diseases, CNS / diagnostic imaging*
Demyelinating Autoimmune Diseases, CNS / immunology
Demyelinating Autoimmune Diseases, CNS / pathology
Demyelinating Autoimmune Diseases, CNS / therapy
Glucocorticoids / therapeutic use
Humans
Magnetic Resonance Imaging
Male
Middle Aged
Myelin-Oligodendrocyte Glycoprotein / immunology*
Plasma Exchange

Substances

Autoantibodies
Glucocorticoids
Myelin-Oligodendrocyte Glycoprotein